SOLV
Solventum Corp

582
Loading...
Loading...
News
all
press releases
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·9d ago
News Placeholder
More News
News Placeholder
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
Zacks·15d ago
News Placeholder
SOLV or MEDP: Which Is the Better Value Stock Right Now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Zacks·17d ago
News Placeholder
Is Solventum Corporation (SOLV) Stock Outpacing Its Medical Peers This Year?
Here is how Solventum (SOLV) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
Zacks·17d ago
News Placeholder
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Zacks·17d ago
News Placeholder
New Strong Buy Stocks for September 16th
FUTU, SITE, CSW, ATRO and SOLV have been added to the Zacks Rank #1 (Strong Buy) List on September 16, 2025.
Zacks·17d ago
News Placeholder
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve
SOLV jumps 5% as Q2 earnings and revenues beat estimates; EPS outlook raised on broad-based segment growth.
Zacks·2mo ago
News Placeholder
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·2mo ago
News Placeholder
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates
Solventum (SOLV) delivered earnings and revenue surprises of +16.55% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Zacks·2mo ago

Latest SOLV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.